These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Drug purchasing. Mehl B Hosp Pharm; 1988 Mar; 23(3):283-6. PubMed ID: 10318047 [No Abstract] [Full Text] [Related]
30. Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002. Andersson K; Petzold MG; Sonesson C; Lönnroth K; Carlsten A Health Policy; 2006 Dec; 79(2-3):231-43. PubMed ID: 16473436 [TBL] [Abstract][Full Text] [Related]
32. Drug prices continue to be relative bargains in inflation-ridden economy. Hosp Purch Manage; 1979 Feb; 4(2):12-3. PubMed ID: 10316767 [No Abstract] [Full Text] [Related]
33. Are generics a drug on the market? Tyler VE J Indiana State Med Assoc; 1980 Jul; 73(7):452-7. PubMed ID: 7452036 [No Abstract] [Full Text] [Related]
34. THE ECONOMICS OF ADVERSE DRUG REACTIONS--case studies. Visconti JA; Smith MC Ann Pharmacother; 2006 Mar; 40(3):529-36. PubMed ID: 16507611 [No Abstract] [Full Text] [Related]
35. Hospital pharmacy symposium on new concepts in parenteral drug delivery. Anderson RW; Cohen JE; Cohen MR; Kleinberg ML; Lewis GR; McAllister JC; Turco SJ Hosp Pharm; 1986 Nov; 21(11):1033-6, 1043-6, 1052-5. PubMed ID: 10317801 [No Abstract] [Full Text] [Related]
36. Diabetes: the cost of illness in Sweden. Henriksson F; Jönsson B J Intern Med; 1998 Dec; 244(6):461-8. PubMed ID: 9893099 [TBL] [Abstract][Full Text] [Related]
37. Regional variations and determinants of direct psychiatric costs in Sweden. Tiainen A; Edman G; Flyckt L; Tomson G; Rehnberg C Scand J Public Health; 2008 Jul; 36(5):483-92. PubMed ID: 18635731 [TBL] [Abstract][Full Text] [Related]
38. Hospital drug prices rise less than 5% per year. Hosp Purch Manage; 1979 May; 4(5):10-1. PubMed ID: 10316803 [No Abstract] [Full Text] [Related]
39. Reflections on a month in the life of the Ontario Drug Benefit Plan. McIsaac W; Naylor CD; Anderson GM; O'Brien BJ CMAJ; 1994 Feb; 150(4):473-7. PubMed ID: 8313259 [No Abstract] [Full Text] [Related]
40. [Economic aspects of the long-term development of a variety of drugs in Czechoslovakia]. Federmann J; Honzáková L Cesk Zdrav; 1981 May; 29(5):212-8. PubMed ID: 7249130 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]